The efficacy and safety of irbesartan/HCTZ [hydrochlorothiazide] combination therapy as first line treatment for patients with moderate hypertension.
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Irbesartan/hydrochlorothiazide (Primary) ; Hydrochlorothiazide; Irbesartan
- Indications Essential hypertension
- Focus Therapeutic Use
- 02 Nov 2006 Status change
- 14 Nov 2005 New trial record.